Andrew Guggenhime
Finanzdirektor/CFO bei VAXCYTE, INC.
Vermögen: 6 Mio $ am 31.05.2023
Aktive Positionen von Andrew Guggenhime
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VAXCYTE, INC. | Finanzdirektor/CFO | 01.05.2020 | - |
Präsident | 01.01.2021 | - | |
Comptroller/Controller/Auditor | - | 01.01.2023 | |
Geschäftsführer | 01.05.2020 | 01.12.2020 | |
CARIBOU BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 01.04.2021 | - |
Independent Dir/Board Member | 01.04.2021 | - |
Karriereverlauf von Andrew Guggenhime
Ehemalige bekannte Positionen von Andrew Guggenhime
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
METACRINE, INC. | Direktor/Vorstandsmitglied | 01.07.2018 | 23.03.2023 |
Independent Dir/Board Member | 01.07.2018 | 23.03.2023 | |
DERMIRA, INC. | Geschäftsführer | 01.04.2014 | 03.05.2018 |
Finanzdirektor/CFO | 01.04.2014 | 01.05.2020 | |
CARDIODX INC | Direktor/Vorstandsmitglied | 28.04.2014 | 01.07.2016 |
Finanzdirektor/CFO | 01.09.2011 | 28.04.2014 | |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Finanzdirektor/CFO | 29.09.2010 | 01.04.2011 |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Finanzdirektor/CFO | 01.12.2008 | 01.06.2010 |
PDL BIOPHARMA, INC. | Finanzdirektor/CFO | 01.04.2006 | 01.12.2008 |
Neoforma, Inc.
Neoforma, Inc. Medical DistributorsDistribution Services Neoforma, Inc. provides e-commerce services to healthcare industry. It also provides supply chain management solutions between hospitals and suppliers. The Company was founded in 1996 and is located in SanJose, CA. | Finanzdirektor/CFO | 01.10.2000 | 01.03.2006 |
Corporate Officer/Principal | 01.01.2000 | 01.10.2000 | |
░░░░░░░ ░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░ ░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Andrew Guggenhime
Middlebury College | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 14 |
Operativ
Director of Finance/CFO | 7 |
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Sektoral
Health Technology | 8 |
Consumer Services | 3 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
WELLS FARGO & COMPANY | Finance |
METACRINE, INC. | Health Technology |
VAXCYTE, INC. | Health Technology |
CARIBOU BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Neoforma, Inc.
Neoforma, Inc. Medical DistributorsDistribution Services Neoforma, Inc. provides e-commerce services to healthcare industry. It also provides supply chain management solutions between hospitals and suppliers. The Company was founded in 1996 and is located in SanJose, CA. | Distribution Services |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Health Technology |
CardioDx, Inc.
CardioDx, Inc. Medical/Nursing ServicesHealth Services CardioDx, Inc. operates as a cardiovascular genomic diagnostics firm. It develops proprietary tests that improve treatment decisions and patient outcomes on coronary artery disease, cardiac arrhythmia, and heart failure. The company was founded by David L. Levison and Christopher R. Burrow in 2004 and is headquartered in Redwood, CA. | Health Services |
Merrill Lynch & Co., Inc. | Finance |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Börse
- Insiders
- Andrew Guggenhime
- Erfahrung